# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $122 p...
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $...
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical t...
JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target fr...
The Change In Rate Is Not Retroactive To January 1, 2024
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price...